Bausch Health
312 hedge funds and large institutions have $3.83B invested in Bausch Health in 2020 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 92 increasing their positions, 109 reducing their positions, and 72 closing their positions.
6.4% more ownership
Funds ownership: 63.38% → 69.78% (+6.4%)
5% less funds holding
Funds holding: 327 → 312 (-15)
16% less repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 109
17% less first-time investments, than exits
New positions opened: 60 | Existing positions closed: 72
24% less call options, than puts
Call options by funds: $99M | Put options by funds: $131M
32% less funds holding in top 10
Funds holding in top 10: 19 → 13 (-6)
43% less capital invested
Capital invested by funds: $6.71B → $3.83B (-$2.88B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$221M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$157M |
| 3 |
HM
HealthCor Management
New York
|
+$92.1M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$72.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$60.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIP
Epoch Investment Partners
New York
|
-$143M |
| 2 |
RA
Rovida Advisors
Fort Lauderdale,
Florida
|
-$35.5M |
| 3 |
SPC
Slate Path Capital
New York
|
-$32.2M |
| 4 |
MVP
Miller Value Partners
Sarasota,
Florida
|
-$25M |
| 5 |
Two Sigma Investments
New York
|
-$24.1M |
BHC Hedge Fund Activity: Q1 2020 in Review
312 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q1 2020, worth a combined $3.83B — down 43% from $6.71B a quarter earlier.
Sellers outnumbered buyers: 72 funds closed out of BHC and 60 opened new positions — a net loss of 12 holders — while 109 trimmed existing stakes and 92 added.
The largest buyer was Morgan Stanley, adding an estimated $221M. The largest seller was Epoch Investment Partners, exiting entirely with an estimated $143M sold.
- 312 institutional investors held Bausch Health (BHC) as of Q1 2020, down from 327 in Q4 2019.
- Funds reported $3.83B of Bausch Health stock for Q1 2020, down 43% quarter-over-quarter.
- 60 funds opened new Bausch Health positions in Q1 2020 and 72 closed out, a net change of -12 holders.
- The largest Bausch Health buyer in Q1 2020 was Morgan Stanley, an estimated $221M added.
- The largest Bausch Health seller in Q1 2020 was Epoch Investment Partners, an estimated $143M sold.
Based on aggregated 13F filings for Q1 2020.